Close Menu

NEW YORK — Co-Diagnostics on Thursday reported first quarter 2020 revenues of $1.5 million, up from $3,400 the year before, primarily due to sales the company's recently launched Logix Smart COVID-19 test for SARS-CoV-2.

Since the commercial launch of Logix Smart COVID-19 in March, Co-Diagnostics has manufactured more than six million tests and recorded COVID-19-related test and equipment sales of over $18 million. The Salt Lake City-based company added that it has also ordered components for more than 20 million additional tests to fill existing and expected orders.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports that genomics is being applied to trace and try to prevent additional COVID-19 waves.

Rady's Children Hospital and San Diego County are teaming up to test pediatric patients and their families for COVID-19 to gauge the spread of the virus locally, according to the San Diego Union-Tribune.

Wildlife managers aim to boost the genetic diversity of Mexican gray wolves by placing captive-born foster pups into packs with similarly aged wild pups, the Mercury News reports.

In Science this week: Genetic Probability tool identifies likely diagnoses in 45 percent of inflammatory arthritis cases, and more.

Sponsored by

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.  

Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.